US 8529885
AAV vectors for in vivo gene therapy of rheumatoid arthritis
granted A61KA61K48/00A61P
Quick answer
US patent 8529885 (AAV vectors for in vivo gene therapy of rheumatoid arthritis) held by ACADEMISCH MEDISCH CENTRUM expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ACADEMISCH MEDISCH CENTRUM
- Grant date
- Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K48/00, A61P, A61P19/02